Senior Researcher / Co-Founder, McCord Research
Iowa City, Iowa Area
- Current
-
- Senior Researcher at McCord Research
- Industry
- Biotechnology
- Websites
Darlene McCord Ph.D.’s Summary
Darlene McCord, Ph.D., FAPWCA
Dr. Darlene McCord is one of the two founders of McCord Research. As senior researcher, she brings a unique blend of scientific credentials to the position. Through her leadership, the company has achieved worldwide recognition in the OTC Drug and Medical Device categories. Her field of specialty is corneotherapy, focusing on the transport of small molecules across the stratum corneum for treatment of skin disorders associated with distressed and wounded skin. Dr. Darlene McCord is widely published on subjects related to immunodermatology and corneotherapy.
Dr. Darlene McCord is known for her work, as a biochemist, in skin and wound care. She has been awarded two patents and six medical devices in the field. She currently has more than 30 skin health products being sold around the world. Dr. Darlene McCord’s most current commercialized skin and wound care product offering is the Remedy brand distributed by Medline Industries. The line is based on a proprietary blend of small molecules called OlivamineTM that provide corneotherapeutic support for diseased skin. Previously, Dr. Darlene McCord developed the Restore line for Hollister and the Cavalon line for 3M.
Dr. Darlene McCord received her first patent in 1993. The patent and the products developed were immediately licensed to one of the country’s premier wound care companies. Her second patent was awarded in 1997. This patent was licensed immediately and the products have become some of the most important in the wound care industry. The second patent is based upon a fetal in-utero wound healing model and its implications for adult wound healing. Dr. Darlene McCord continues to pursue her interests in skin repair systems, barrier repair systems, cancer, and diabetes.
Dr. Darlene McCord’s work has led to global recognition in the field of skin and wound repair. Her mission remains improving the quality of life for people in every country of the world.
Darlene McCord Ph.D.’s Experience
-
Senior Researcher
McCord Research
(Biotechnology industry)
January 1980 — Present (29 years 11 months)
Dr. Darlene McCord is one of the two founders of McCord Research. As senior researcher, she brings a unique blend of scientific credentials to the position. Through her leadership, the company has achieved worldwide recognition in the OTC Drug and Medical Device categories. Her field of specialty is corneotherapy, focusing on the transport of small molecules across the stratum corneum for treatment of skin disorders associated with distressed and wounded skin. Dr. Darlene McCord is widely published on subjects related to immunodermatology and corneotherapy.
Additional Information
Darlene McCord Ph.D.’s Websites:
Darlene McCord Ph.D.’s Interests:
Dr. Darlene McCord is one of the two founders of McCord Research. As senior researcher, she brings a unique blend of scientific credentials to the position. Through her leadership, the company has achieved worldwide recognition in the OTC Drug and Medical Device categories. Her field of specialty is corneotherapy, focusing on the transport of small molecules across the stratum corneum for treatment of skin disorders associated with distressed and wounded skin. Dr. Darlene McCord is widely published on subjects related to immunodermatology and corneotherapy.
Darlene McCord Ph.D.’s Groups:
Dr. Darlene McCord is a member of the American Professional Wound Care Association (APWCA)
-
Darlene McCord -
McCord Research
Darlene McCord Ph.D.’s Honors:
Dr. Darlene McCord is known for her work, as a biochemist, in skin and wound care. She has been awarded two patents and six medical devices in the field. She currently has more than 30 skin health products being sold around the world. Dr. Darlene McCord’s most current commercialized skin and wound care product offering is the Remedy brand distributed by Medline Industries. The line is based on a proprietary blend of small molecules called OlivamineTM that provide corneotherapeutic support for diseased skin. Previously, Dr. Darlene McCord developed the Restore line for Hollister and the Cavalon line for 3M. She is currently working with the University of Iowa on compounds that may reverse early stages of necrosis and that can activate GO quiescent cells in the chronic wound environment.
Darlene McCord Ph.D.’s Contact Settings
Interested In:
- career opportunities
- consulting offers
- new ventures
- job inquiries
- expertise requests
- business deals
- reference requests
- getting back in touch
